Skip to content

Research results with Re5 technology for Parkinson's disease

  • Approximately 15% improved movement speed
  • Significantly increased erythropoietin (EPO) cerebrospinal fluid levels
  • Functional improvement driven by increased levels of dopamine in the brain and possibly EPO-induced neural repair and/or protection of dopaminergic neurons
  • No serious side effects or adverse events
  • Re5 technology is currently only in clinical trials for Parkinson's disease

The research results presented

Parkinson's Disease research with Re5

Long-term treatment with transcranial pulsed electromagnetic fields improves movement speed and elevates cerebrospinal erythropoietin in Parkinson's disease (2021)

The effect of 8 weeks of treatment with transcranial pulsed electromagnetic fields on hand tremor and inter-hand coherence in persons with Parkinson's disease (2019)

The Hawthorne effect as a pre-placebo expectation in Parkinson's disease patients participating in a randomized placebo-controlled clinical study (2019)

Effects of Long-Term Treatment with T-PEMF on Forearm Muscle Activation and Motor Function in Parkinson's Disease (2018)

Effect of T-PEMF on functional rate of force development and movement speed in persons with Parkinson's disease: A randomized clinical trial (2018)

Effects of transcranial pulsed electromagnetic field stimulation on quality of life in Parkinson's disease (2018)

Parkinson's Disease and Transcranial Pulsed Electromagnetic Fields: A Randomized Clinical Trial (2017)

Effect of pulsed electromagnetic fields in patients with idiopathic Parkinson's disease: A pilot study (2008)

Sign up for our newsletter